Search Results

Clearwater France advises Capital Croissance and Turenne Capital on the sale of a majority stake of BIOBank

Clearwater outperforms in 2023 and expects improving conditions and growth in 2024

Our US partner

Clearwater has advised the shareholders of Didactic on the sale of a majority stake in the Group to FCDE

Alexandre Forget

I co-manage Clearwater's activity in the Mediterranean region, alongside Emmanuel Xerri. Following a career in large cap companies in London working for CIBC Capital Markets, I quickly moved into the small and mid-cap segment working for Degroof Petercam, CIC Conseil and then Clairfield International to advise families and shareholders on their strategic considerations. Our goal is to accompany our clients over the long term, by reconciling our technical expertise of the large cap market with tailor-made solutions which meet the specificities and challenges of SMEs. I have advised on more than 30 transactions, including the sale of Markal, a major player in organic food, to FrenchFood Capital, the sale of Laboratoire BioCasamance, a medical analysis laboratory, to Eurofins, the sale of Bio&Co, an organic distribution network, to InVivo, the acquisition of Maxicoffee, a coffee roaster and e-commerce business, by the Daltys group, BPI France and the Qatar sovereign wealth fund’s (QIA) investment in Alstef Group, an Industry 4.0 logistics solutions company, and the refinancing of laser cutting business GL Groupe and PSD, a pharmaceutical group. I am convinced that Clearwater's three-dimensional approach of sector expertise, regional proximity and international footprint is a differentiator for our clients.

Clearwater predicts increasing activity over the next 12 months